Professor Michael Inouye is a leading systems genomics and population health researcher at the University of Cambridge (Department of Public Health and Primary Care) and Baker Heart & Diabetes Institute (Melbourne). His work bridges statistical genetics, computational biology, and clinical translation, with a focus on cardiovascular/respiratory diseases and sustainable research practices. Director of Research (Research Professor) since 2021 Honorary Professorial Fellow at University of Melbourne since 2021 Co-leader of Cambridge Baker Systems Genomics Initiative since 2017 Research Interests include: Polygenic risk score development and clinical implementation Multi-omic integration (genomics, proteomics, microbiomics) Host-microbiome interactions in disease Sustainable computational methodologies Cardiometabolic disease prevention Scientific Contributions show leadership in: Developing the Polygenic Score Catalog infrastructure Creating environmentally sustainable algorithmic frameworks Elucidating microbiome contributions to chronic diseases Advancing multi-modal risk prediction models Integrating genetic and metabolic pathway analysis Recent Publications demonstrate expertise across: Polygenic score optimization for blood traits and diabetes Microbiome-disease interaction networks Computational sustainability in biomedical research Cardiovascular risk stratification Multi-omic data harmonization Genetic determinants of molecular phenotypes











